COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for release of actual court opinion or docket update; current filing appears to be a system-generated placeholder with no legal substance
BIIB drugs
BIIB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$186.93
T+0 close · Mar 30, 2026 · via day close
Latest settled
+6.77%
T+60 · $199.59
Vs SPY
−9.25%
α at T+60
Horizons
All settled
through T+60
- T+0 · Mar 30 $186.93entry
- T+1 · 8mo ago −2.36%α −5.25% · $182.52
- T+5 · 7mo ago −6.05%α −10.35% · $175.61
- T+20 · 7mo ago −2.03%α −14.63% · $183.13
- T+60 · 5mo ago +6.77%α −9.25% · $199.59
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Court Ruling Details
Court
United States District Court for the Northern District of Illinois
Court Level
District
Case Type
contract
Ruling Type
other
Outcome
NULL
Precedent Risk
LOW
Key Facts
- Case: Walgreen Co. et al v. Biogen, Inc. (1:25-cv-11680), filed in the United States District Court for the Northern District of Illinois
- Filed on 2026-03-30, status is unknown
- No substantive opinion or ruling text available, only a procedural placeholder or login redirect was provided
Financial Impact
No financial impact can be assessed due to lack of content
Risk Factors
- Potential for material ruling once full opinion is released
- Uncertainty due to lack of accessible ruling details
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
47% bullish (43 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-3qxgjdmg-BIIB |
Track record
34 reports on BIIB
10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $251.65 −0.69% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $253.25 Now $251.65 −0.63% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $254.87 Now $251.65 −1.26% settles Feb 5
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 19, 202628d ago Press Release Neutral 4/10 Entry $233.48 Now $251.65 +7.78% settles Jan 14
- Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $251.65 +9.69% settles Jan 7
- Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $251.65 +14.45% settles Dec 29
- Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $251.65 +16.77% settles Dec 14
- Sep 3, 202610w ago Press Release Neutral 4/10 Entry $220.83 Now $251.65 +13.96% settles Dec 1
Showing 10 of 34
US Market Status
Market Closed · Opens Wed (11h 21m)
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers